查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598503

經導管肺動脈瓣市場：按技術、原料、應用和最終用途分類 - 全球預測 2025-2030

Transcatheter Pulmonary Valve Market by Technology, Raw Material, Application, End Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年經導管肺動脈瓣市場估值為6353萬美元，預計到2024年將達到6976萬美元，複合年成長率為9.90%，到2030年將達到12308萬美元。

經導管肺動脈瓣（TPV）市場包括無需開胸手術即可治療先天性心臟疾病和肺動脈瓣閉鎖不全的微創手術。其範圍和定義包括透過基於導管的方法輸送的人工瓣膜的設計和應用，為流出道先前已修復的患者提供治療選擇。這種需求源於對因禁忌症或高手術風險而無法進行外科瓣膜置換術的患者提供更安全、侵入性更小的解決方案的需求。最終用途主要用於患有先天性心臟疾病的兒科和成人患者，特別是那些先前修復的導管退化的患者。推動市場成長的關鍵因素包括先天性心臟疾病盛行率的增加、介入性心臟病學的進步以及對微創手術的日益偏好。閥門設計和材料的技術進步不僅帶來了巨大的商機，而且隨著人們對經導管治療的認知不斷提高，也帶來了一個開拓的新興市場。然而，高昂的程序成本、監管挑戰以及某些地區的專業知識有限等限制因素阻礙了成長。此外，程序的複雜性以及需要長期資料來支持耐久性和有效性，這對市場擴張構成了進一步的挑戰。創新領域包括開發更耐用和生物相容性材料、增強診斷成像技術以提高準確性以及將覆蓋範圍擴大到更廣泛的解剖範圍。此外，公司可以專注於上市後監督和利用真實資料進行迭代改進。 TPV 市場是一個充滿活力的市場，受到循環系統領域持續的研發投資、策略聯盟和收購的支持。市場參與者應利用與醫療保健提供者和監管機構的夥伴關係關係來克服挑戰並利用對微創解決方案不斷成長的需求。透過培育專注於以患者為中心的結果和具有成本效益的解決方案的創新生態系統，公司可以加強其市場定位並解決治療領域的現有差距。

主要市場統計
基準年[2023] 6353萬美元
預測年份 [2024] 6976萬美元
預測年份 [2030] 12308萬美元
複合年成長率（%） 9.90%

市場動態：快速發展的經導管肺動脈瓣市場的關鍵市場洞察

供需的動態交互作用正在改變經導管肺動脈瓣市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 各種心血管疾病的盛行率增加
    • 心臟瓣膜疾病人口不斷增加，對肺動脈瓣置換術的需求迅速增加
    • 提高對經導管肺動脈瓣治療的認知
  • 市場限制因素
    • 核准流程嚴格規定
  • 市場機會
    • 瓣膜置換術的技術進步
    • 與經導管心臟瓣膜技術相關的產品發布數量增加
  • 市場挑戰
    • 替代技術的可用性

波特的五力：駕馭經導管肺動脈瓣市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解經導管肺動脈瓣市場的外部影響

外部宏觀環境因素在塑造經導管肺動脈瓣市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解經導管肺動脈瓣市場的競爭格局

經導管肺動脈瓣市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣經導管肺動脈瓣市場供應商的績效評估

FPNV 定位矩陣是評估經導管肺動脈瓣市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製經導管肺動脈瓣市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對經導管肺動脈瓣市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 各種心血管疾病的盛行率增加
      • 心臟瓣膜疾病患者數量不斷增加，肺動脈瓣置換需求快速成長
      • 提高對經導管肺動脈瓣治療的認知
    • 抑制因素
      • 核准流程嚴格規定
    • 機會
      • 瓣膜置換手術的技術進步
      • 增加經導管心臟瓣膜技術相關的產品發布
    • 任務
      • 替代技術的可用性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章經導管肺動脈瓣市場：依技術分類

  • 球囊擴張型經導管瓣膜
  • 自膨脹式經導管瓣膜

第7章經導管肺動脈瓣市場：依原料分類

  • 合成經導管瓣膜
  • 組織工程經導管瓣膜

第8章經導管肺動脈瓣市場：依應用分類

  • 心臟異常
  • 肺動脈閉鎖
  • 肺逆流症
  • 肺動脈狹窄
  • 法洛氏四合症
  • 動脈幹

第9章經導管肺動脈瓣市場：依最終用途分類

  • 成人用
  • 小兒科

第10章美洲經導管肺動脈瓣市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太經導管肺動脈瓣市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲經導管肺動脈瓣市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Boston Scientific Corporation
  • Colibri Heart Valve, LLC
  • Commonwealth Edison Company
  • CryoLife, Inc.
  • Direct Flow Medical, Inc.
  • Edwards Lifesciences Corporation
  • JenaValve Technology, Inc.
  • Jude Medical Inc.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • SYMETIS
  • ValveXchange, Inc.
  • Venus MedTech HangZhou Inc
  • Xeltis AG
Product Code: MRR-03168519576D

The Transcatheter Pulmonary Valve Market was valued at USD 63.53 million in 2023, expected to reach USD 69.76 million in 2024, and is projected to grow at a CAGR of 9.90%, to USD 123.08 million by 2030.

The Transcatheter Pulmonary Valve (TPV) market involves minimally invasive procedures to treat congenital heart defects and pulmonary valve dysfunction without open-heart surgery. Scope and definition encompass the design and application of prosthetic valves delivered via catheter-based methods, offering therapeutic alternatives for patients with previously repaired outflow tracts. Necessity stems from the demand for safer, less invasive solutions for patients inadequately served by surgical valve replacement due to contraindications or high surgical risk. End-use applications primarily lie within pediatric and adult populations with congenital heart defects, particularly benefiting those with previously repaired conduits experiencing degeneration. Key market growth influencers include the increasing prevalence of congenital heart diseases, advances in interventional cardiology, and a growing preference for minimally invasive procedures. Technological advancements in valve design and materials present significant opportunities, as well as untapped emerging markets with a rising awareness of transcatheter therapies. However, limitations such as high procedural costs, regulatory challenges, and limited expertise in certain regions pose growth barriers. Moreover, procedural complexities and the need for long-term data to support durability and effectiveness further challenge market expansion. Areas ripe for innovation include the development of more durable and biocompatible materials, enhanced imaging techniques for precision, and novel delivery mechanisms that expand application reach to broader anatomical considerations. Additionally, companies could focus on post-market surveillance and iterative improvements driven by real-world data. The TPV market is dynamic, supported by continuous R&D investments, strategic collaborations, and acquisitions in the cardiovascular space. Market players should leverage partnerships with healthcare providers and regulatory bodies to navigate challenges and capitalize on the burgeoning demand for minimally invasive solutions. By fostering an innovative ecosystem focused on patient-centric outcomes and cost-effective solutions, companies can strengthen their market positioning and address existing gaps in the treatment landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 63.53 million
Estimated Year [2024] USD 69.76 million
Forecast Year [2030] USD 123.08 million
CAGR (%) 9.90%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transcatheter Pulmonary Valve Market

The Transcatheter Pulmonary Valve Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of various cardiovascular diseases
    • Growing population with heart valve disorders and surging demand for pulmonary valve replacement
    • Increasing awareness of transcatheter pulmonary valve therapy
  • Market Restraints
    • Stringent regulations for approval process
  • Market Opportunities
    • Technological advancement in valve replacement procedures
    • Growing number of product launches related to transcatheter heart valve technologies
  • Market Challenges
    • The availability of alternative technologies

Porter's Five Forces: A Strategic Tool for Navigating the Transcatheter Pulmonary Valve Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transcatheter Pulmonary Valve Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transcatheter Pulmonary Valve Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transcatheter Pulmonary Valve Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transcatheter Pulmonary Valve Market

A detailed market share analysis in the Transcatheter Pulmonary Valve Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transcatheter Pulmonary Valve Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transcatheter Pulmonary Valve Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Transcatheter Pulmonary Valve Market

A strategic analysis of the Transcatheter Pulmonary Valve Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Transcatheter Pulmonary Valve Market, highlighting leading vendors and their innovative profiles. These include Boston Scientific Corporation, Colibri Heart Valve, LLC, Commonwealth Edison Company, CryoLife, Inc., Direct Flow Medical, Inc., Edwards Lifesciences Corporation, JenaValve Technology, Inc., Jude Medical Inc., Lepu Medical Technology (Beijing) Co., Ltd., LivaNova PLC, Medtronic PLC, SYMETIS, ValveXchange, Inc., Venus MedTech HangZhou Inc, and Xeltis AG.

Market Segmentation & Coverage

This research report categorizes the Transcatheter Pulmonary Valve Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Balloon-Expanded Transcatheter Valve and Self-Expanded Transcatheter Valve.
  • Based on Raw Material, market is studied across Synthetic Transcatheter Valve and Tissue Engineered Transcatheter Valve.
  • Based on Application, market is studied across Cardiac Anomaly, Pulmonary Atresia, Pulmonary Regurgitation, Pulmonary Stenosis, Tetralogy Of Fallot, and Truncus Arteriosus.
  • Based on End Use, market is studied across Adult and Pediatric.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of various cardiovascular diseases
      • 5.1.1.2. Growing population with heart valve disorders and surging demand for pulmonary valve replacement
      • 5.1.1.3. Increasing awareness of transcatheter pulmonary valve therapy
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulations for approval process
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in valve replacement procedures
      • 5.1.3.2. Growing number of product launches related to transcatheter heart valve technologies
    • 5.1.4. Challenges
      • 5.1.4.1. The availability of alternative technologies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Transcatheter Pulmonary Valve Market, by Technology

  • 6.1. Introduction
  • 6.2. Balloon-Expanded Transcatheter Valve
  • 6.3. Self-Expanded Transcatheter Valve

7. Transcatheter Pulmonary Valve Market, by Raw Material

  • 7.1. Introduction
  • 7.2. Synthetic Transcatheter Valve
  • 7.3. Tissue Engineered Transcatheter Valve

8. Transcatheter Pulmonary Valve Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiac Anomaly
  • 8.3. Pulmonary Atresia
  • 8.4. Pulmonary Regurgitation
  • 8.5. Pulmonary Stenosis
  • 8.6. Tetralogy Of Fallot
  • 8.7. Truncus Arteriosus

9. Transcatheter Pulmonary Valve Market, by End Use

  • 9.1. Introduction
  • 9.2. Adult
  • 9.3. Pediatric

10. Americas Transcatheter Pulmonary Valve Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Transcatheter Pulmonary Valve Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Transcatheter Pulmonary Valve Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Boston Scientific Corporation
  • 2. Colibri Heart Valve, LLC
  • 3. Commonwealth Edison Company
  • 4. CryoLife, Inc.
  • 5. Direct Flow Medical, Inc.
  • 6. Edwards Lifesciences Corporation
  • 7. JenaValve Technology, Inc.
  • 8. Jude Medical Inc.
  • 9. Lepu Medical Technology (Beijing) Co., Ltd.
  • 10. LivaNova PLC
  • 11. Medtronic PLC
  • 12. SYMETIS
  • 13. ValveXchange, Inc.
  • 14. Venus MedTech HangZhou Inc
  • 15. Xeltis AG

LIST OF FIGURES

  • FIGURE 1. TRANSCATHETER PULMONARY VALVE MARKET RESEARCH PROCESS
  • FIGURE 2. TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. TRANSCATHETER PULMONARY VALVE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. TRANSCATHETER PULMONARY VALVE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TRANSCATHETER PULMONARY VALVE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSCATHETER PULMONARY VALVE MARKET DYNAMICS
  • TABLE 7. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY BALLOON-EXPANDED TRANSCATHETER VALVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY SELF-EXPANDED TRANSCATHETER VALVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY SYNTHETIC TRANSCATHETER VALVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TISSUE ENGINEERED TRANSCATHETER VALVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY CARDIAC ANOMALY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PULMONARY ATRESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PULMONARY REGURGITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PULMONARY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TETRALOGY OF FALLOT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TRUNCUS ARTERIOSUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 191. TRANSCATHETER PULMONARY VALVE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. TRANSCATHETER PULMONARY VALVE MARKET, FPNV POSITIONING MATRIX, 2023